Featured news
Blog
Announcement
science & technology
Xconomy
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
Blog
Announcement
science & technology
Forbes
Blog
Announcement
science & technology
Xconomy
Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
All news
Blog
announcement
science & technology
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
November 19, 2024
Blog
announcement
science & technology
Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
September 18, 2024
Blog
announcement
science & technology
Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
July 30, 2024
Blog
announcement
science & technology
Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
April 29, 2024
Blog
announcement
science & technology
Asimov launches LV Edge Packaging System to optimize lentivirus production
Asimov launches LV Edge Packaging System to optimize lentivirus production
Asimov launches LV Edge Packaging System to optimize lentivirus production
January 29, 2024
Blog
announcement
science & technology
Announcing Asimov Press
Announcing Asimov Press
Announcing Asimov Press
September 5, 2023
Blog
announcement
science & technology
Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 11, 2023
Blog
announcement
science & technology
Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
February 8, 2023
Blog
announcement
science & technology
Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
January 18, 2023
Blog
announcement
science & technology
Forbes
Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
January 5, 2023
Blog
announcement
science & technology
Scientific American
Cellular Circuit Computes with DNA
Cellular Circuit Computes with DNA
April 1, 2016
Blog
announcement
science & technology
Massachusetts Institute of Technology
A programming language for living cells
A programming language for living cells
March 31, 2016
No items found.
Blog
announcement
science & technology
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
November 19, 2024
Blog
announcement
science & technology
Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
September 18, 2024
Blog
announcement
science & technology
Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
July 30, 2024
Blog
announcement
science & technology
Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
April 29, 2024
Blog
announcement
science & technology
Asimov launches LV Edge Packaging System to optimize lentivirus production
Asimov launches LV Edge Packaging System to optimize lentivirus production
Asimov launches LV Edge Packaging System to optimize lentivirus production
January 29, 2024
Blog
announcement
science & technology
Announcing Asimov Press
Announcing Asimov Press
Announcing Asimov Press
September 5, 2023
Blog
announcement
science & technology
Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 11, 2023
Blog
announcement
science & technology
Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
February 8, 2023
Blog
announcement
science & technology
Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
January 18, 2023
Blog
announcement
science & technology
Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
January 5, 2023
No items found.
Learn about biology through the eyes of our founders
Synthetic Biology: Programming Living Bacteria
Christopher Voigt
The Future Will Be Genetically Engineered
Alec Nielsen
